Nebenwirkungen · Zolsketil pegylated liposomal
ZOLSKETIL pegylated liposomal 2 mg/mL concentrate for dispersion for infusion · Abschnitt 4.8 · PDF-Seite 10–12
HOS-146360 · Präparat HOS-099502
10 Neoplasms Myelodysplastic syndromeb benign, Oral neoplasmb malignant and unspecified (including cysts and polyps) Blood and Very common Leukopaenia lymphatic Neutropaenia system disorders Lymphopaenia Anaemia (including hypochromic) Common Thrombocytopaenia Febrile neutropaenia Uncommon Pancytopaenia Thrombocytosis Rare Bone marrow failure Immune Uncommon Hypersensitivity system Anaphylactic reaction disorders Rare Anaphylactoid reaction Metabolism Very common Decreased appetite and nutrition Common Cachexia disorders Dehydration Hypokalaemia Hyponatraemia Hypocalcaemia Uncommon Hyperkalaemia Hypomagnesaemia Psychiatri Common Confusional state c Anxiety disorders Depression Insomnia Nervous Common Neuropathy peripheral system Peripheral sensory neuropathy disorders Neuralgia Paraesthesia Hypoaesthesia Dysgeusia Headache Lethargy Dizziness Uncommon Polyneuropathy Convulsion Syncope Dysaesthesia Somnolence Eye disorders Common Conjunctivitis Uncommon Vision blurred Lacrimation increased Rare Retinitis Cardiac Common Tachycardia disorders Uncommon Palpitations a Cardiac arrest Cardiac failure Cardiac failure congestive Cardiomyopathy 11 Cardiotoxicity Rare Ventricular arrhythmia Bundle branch block right Conduction disorder Atrioventricular block Cyanosis Vascula Common Hypertension r Hypotension disorder s
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2026-04-16T15:10:00Z · SHA-256 749f25cb02ef3c2557fff9c44c8608815445daccd9aad038fce4e840c7fa1845 · Passage 4a74134d51e41bfcfb4cf87d5826498732060e00d23ffed6bd3f577cf3d8889d · Zeichen 3466–6432 im Abschnitt